How to buy T2 Biosystms stock (TTOO)

T2 Biosystms is a diagnostics & research business based in the US. T2 Biosystms shares (TTOO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.35 – a decrease of 1.43% over the previous week. T2 Biosystms employs 113 staff and has a trailing 12-month revenue of around $7.2 million.

Our top picks for where to buy T2 Biosystms stock

Buy T2 Biosystms stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

T2 Biosystms stock price (NASDAQ: TTOO)

Use our graph to track the performance of TTOO stocks over time.

T2 Biosystms shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$0.35
52-week range	$0.31 - $8.38
50-day moving average more info button	$1.24
200-day moving average more info button	$3.48
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.03

Is it a good time to buy T2 Biosystms stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

T2 Biosystms price performance over time

Historical closes compared with the close of $0.35 from 2024-12-20

1 week (2024-12-18)	0.35
1 month (2024-11-25)	-28.57%
3 months (2024-09-25)	-82.59%
6 months (2024-06-25)	-94.12%

1 year (2023-12-22)	-93.30%
2 years (2022-12-23)	-99.69%
3 years (2021-12-23)	2573.5
5 years (2019-12-24)	5650

T2 Biosystms financials

Revenue TTM	$7.2 million
Gross profit TTM	$-24,766,000
Return on assets TTM	-90.46%
Return on equity TTM	-622.14%
Profit margin	0%
Book value	$-6.91
Market Capitalization more info button	$10.5 million

TTM: trailing 12 months

T2 Biosystms share dividends

We're not expecting T2 Biosystms to pay a dividend over the next 12 months.

Have T2 Biosystms's shares ever split?

T2 Biosystms's shares were split on a 1:100 basis on 12 October 2023 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your T2 Biosystms shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for T2 Biosystms shares which in turn could have impacted T2 Biosystms's share price.

T2 Biosystms share price volatility

Over the last 12 months, T2 Biosystms's shares have ranged in value from as little as $0.31 up to $8.3799. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while T2 Biosystms's is 0.376. This would suggest that T2 Biosystms's shares are less volatile than average (for this exchange).

T2 Biosystms overview

T2 Biosystems, Inc. , an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Frequently asked questions

What percentage of T2 Biosystms is owned by insiders or institutions?
Currently 10.168% of T2 Biosystms shares are held by insiders and 73.513% by institutions. How many people work for T2 Biosystms?
Latest data suggests 113 work at T2 Biosystms. When does the fiscal year end for T2 Biosystms?
T2 Biosystms's fiscal year ends in December. Where is T2 Biosystms based?
T2 Biosystms's address is: 101 Hartwell Avenue, Lexington, MA, United States, 02421 What is T2 Biosystms's ISIN number?
T2 Biosystms's international securities identification number is: US89853L1044 What is T2 Biosystms's CUSIP number?
T2 Biosystms's Committee on Uniform Securities Identification Procedures number is: 89853L104